VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $87,301 | -23.6% | 9,317 | +99.9% | 0.00% | – |
Q2 2023 | $114,334 | +22.2% | 4,661 | +15.9% | 0.00% | – |
Q1 2023 | $93,570 | -7.8% | 4,021 | +0.3% | 0.00% | – |
Q4 2022 | $101,443 | +407.2% | 4,008 | +274.2% | 0.00% | – |
Q3 2022 | $20,000 | -82.5% | 1,071 | -75.8% | 0.00% | – |
Q2 2022 | $114,000 | +11300.0% | 4,433 | +16950.0% | 0.00% | – |
Q3 2020 | $1,000 | -87.5% | 26 | -88.0% | 0.00% | – |
Q1 2020 | $8,000 | – | 216 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |